ClinicalTrials.gov record
Active, not recruiting Phase 1Phase 2 Interventional

Study of Zifibancimig in Participants With Neovascular Age-related Macular Degeneration

ClinicalTrials.gov ID: NCT04567303

Public ClinicalTrials.gov record NCT04567303. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 4:26 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Three-part, Phase I/II Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Zifibancimig Following Intravitreal Administration of Multiple Ascending Doses and Continuous Delivery From the Port Delivery in Patients With Neovascular Age-related Macular Degeneration

Study identification

NCT ID
NCT04567303
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
177 participants

Conditions and interventions

Interventions

  • Port Delivery Platform Device
  • Ranibizumab Drug
  • Zifibancimig Drug

Device · Drug

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 27, 2020
Primary completion
Jul 31, 2026
Completion
Jul 31, 2026
Last update posted
May 5, 2026

2020 – 2026

United States locations

U.S. sites
38
U.S. states
22
U.S. cities
37
Facility City State ZIP Site status
Barnet Dulaney Perkins Eye Center Mesa Arizona 85206
Associated Retina Consultants Phoenix Arizona 85020
The Retina Partners Encino California 91436
Retinal Consultants Med Group Sacramento California 95841
Orange County Retina Med Group Santa Ana California 92705
Southwest Retina Consultants Durango Colorado 81303
Retina Vitreous Assoc of FL St. Petersburg Florida 33711
Southern Vitreoretinal Assoc Tallahassee Florida 32308
Retina Associates of Florida, LLC Tampa Florida 33609
Southeast Retina Center Augusta Georgia 30909
University Retina and Macula Associates, PC Oak Forest Illinois 60452
Maine Eye Center Portland Maine 04101
Johns Hopkins Med Baltimore Maryland 21287
Retina Group of Washington Chevy Chase Maryland 20815
Cumberland Valley Retina Consultants Hagerstown Maryland 21740
Foundation for Vision Research Grand Rapids Michigan 49546
Associated Retinal Consultants Royal Oak Michigan 48073
VitreoRetinal Surgery, PLLC. Saint Louis Park Minnesota 55416
The Retina Institute St Louis Missouri 63128
Sierra Eye Associates Reno Nevada 89502
Envision Ocular, LLC Bloomfield New Jersey 07003
Retina Vit Surgeons/Central NY Liverpool New York 13088
Duke Eye Center Durham North Carolina 27705
Graystone Eye Hickory North Carolina 28602
OSU Eye Physicians & Surgeons Columbus Ohio 43212
Mid Atlantic Retina - Wills Eye Hospital Philadelphia Pennsylvania 19107
Carolina Eyecare Physicians Mt. Pleasant South Carolina 29464
Charles Retina Institute Germantown Tennessee 38138
Southeastern Retina Associates Knoxville Tennessee 37922
Tennessee Retina PC. Nashville Tennessee 37203
Austin Research Center for Retina Austin Texas 78705
Austin Clinical Research LLC Austin Texas 78750
Retina Consultants of Texas Bellaire Texas 77401
Retina Consultants of Texas Houston Texas 77030
Retina Center of Texas Southlake Texas 76092
Piedmont Eye Center Lynchburg Virginia 24502
Wagner Kapoor Institute Norfolk Virginia 23502
Spokane Eye Clinical Research Spokane Washington 99204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04567303, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 5, 2026 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04567303 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →